Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AsfiledCriticalH Lundbeck As
Priority claimed from EP17734307.6Aexternal-prioritypatent/EP3478681B1/fr
Publication of MA45537B1publicationCriticalpatent/MA45537B1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La présente invention propose des 1h-pyrazolo [4,3-b] pyridin-7-amines de formule (i) comme inhibiteurs de la pde1 et leur utilisation comme médicament, en particulier pour le traitement de troubles neurodégénératifs et de troubles psychiatriques.
MA45537A2016-07-042017-06-301h-pyrazolo [4,3-b]pyridines en tant qu'inhibiteurs de pde1
MA45537B1
(fr)
5,6,7,8-tétrahydro[1,2,4]triazolo[4,3- a]pyridin-3(2h)-ones et 2,5,6,7-tétrahydro-3h-pyrrolo[2,1 -c][1,2,4]triazol-3-ones substituées et leur utilisation
Combinaţie nouă dintre 8-ciclopropil-3-[2-(3-fluorofenil)etil]-7,8-dihidro-3H-[1,3]oxazino[6,5-g][1,2,3]benzotriazin-4,9-dionă şi un inhibitor al acetilcolinesterazei şi compoziţii farmaceutice care o conţin